{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:58:21Z","timestamp":1768427901958,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083844\/z\/07\/Z"],"award-info":[{"award-number":["083844\/z\/07\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.10.111","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T05:29:38Z","timestamp":1446701378000},"page":"7283-7289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag\u2013pol\u2013nef antigen"],"prefix":"10.1016","volume":"33","author":[{"given":"S.","family":"Herath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Le Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tatoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.111_bib0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/COH.0b013e32833d2d2b","article-title":"Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag\/pol\/nef subtype B HIV vaccine","volume":"5","author":"Gray","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0180","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fmicb.2014.00439","article-title":"The influence of delivery vectors on HIV vaccine efficacy","volume":"5","author":"Ondondo","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel adenovirus vector-based vaccines for HIV-1","volume":"5","author":"Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0200","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/eji.201242624","article-title":"T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV\/NDK challenge virus load","volume":"42","author":"Roshorm","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0205","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1016\/j.vaccine.2009.07.050","article-title":"Heterologous prime\/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors","volume":"27","author":"Santra","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0210","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0215","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0220","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0225","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0230","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0235","doi-asserted-by":"crossref","first-page":"e107903","DOI":"10.1371\/journal.pone.0107903","article-title":"Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure","volume":"9","author":"Biswas","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0240","doi-asserted-by":"crossref","first-page":"300ra127","DOI":"10.1126\/scitranslmed.aac5757","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0245","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0255","doi-asserted-by":"crossref","first-page":"e1003776","DOI":"10.1371\/journal.pcbi.1003776","article-title":"The fitness landscape of HIV-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing","volume":"10","author":"Mann","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0260","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/14760584.2014.861748","article-title":"Novel approaches in polyepitope T-cell vaccine development against HIV-1","volume":"13","author":"Karpenko","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0270","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","article-title":"Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression","volume":"178","author":"Sacha","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0275","doi-asserted-by":"crossref","first-page":"e73117","DOI":"10.1371\/journal.pone.0073117","article-title":"Nef-specific CD8+ T cell responses contribute to HIV-1 immune control","volume":"8","author":"Adland","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0280","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1016\/j.vaccine.2009.06.028","article-title":"Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity","volume":"27","author":"Gabitzsch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0285","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2008.12.051","article-title":"A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines","volume":"27","author":"Peruzzi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0290","doi-asserted-by":"crossref","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0295","doi-asserted-by":"crossref","first-page":"e84707","DOI":"10.1371\/journal.pone.0084707","article-title":"Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen","volume":"9","author":"McKay","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.76.1.127-135.2002","article-title":"Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response","volume":"76","author":"Molinier-Frenkel","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0310","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.02563-09","article-title":"Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes","volume":"84","author":"Kaufman","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0315","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2009.03.006","article-title":"In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation","volume":"27","author":"Johnson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0320","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2013.06.102","article-title":"Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)","volume":"31","author":"Launay","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0325","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.vaccine.2011.04.080","article-title":"Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses","volume":"29","author":"Liard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0330","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1021\/mp100009e","article-title":"Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity","volume":"7","author":"Kuo-Haller","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0335","doi-asserted-by":"crossref","first-page":"e91366","DOI":"10.1371\/journal.pone.0091366","article-title":"Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)","volume":"9","author":"Enama","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.111_bib0340","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","article-title":"Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications","volume":"304","author":"Pillon","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:41:44Z","timestamp":1565408504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15015674"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.111","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag\u2013pol\u2013nef antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}